If

Product Description

Ifin is a pharmaceutical formulation containing Terbinafine Hydrochloride as its active component. This antifungal agent is clinically indicated for the treatment of diverse fungal infections.

Uses

Ifin is therapeutically employed for managing various fungal infections, including dermatophytoses (ringworm), tinea cruris (jock itch), tinea pedis (athlete’s foot), and fungal infections affecting the scalp (tinea capitis) and nail beds (onychomycosis).

How to Use

Administer Ifin orally, typically as a single daily dose or according to medical prescription. While it may be taken with or without food, consumption with meals is often recommended to minimize gastrointestinal discomfort. The treatment regimen (dosage and duration) is determined by the specific infection type and individual therapeutic response.

Mechanism of Action

The active principle, Terbinafine Hydrochloride, exerts its antifungal effect by selectively inhibiting squalene epoxidase, a crucial enzyme in fungal ergosterol biosynthesis. This disruption of cell membrane synthesis results in fungicidal activity against susceptible organisms.

Therapeutic Benefits

Ifin demonstrates rapid clinical efficacy in resolving fungal infections while alleviating associated symptoms such as pruritus, erythema, and discomfort. Completion of the prescribed course ensures eradication of the infection and prevents recurrence or dissemination.

Adverse Effects

Common adverse reactions may include gastrointestinal disturbances (dyspepsia, abdominal discomfort, diarrhea), transient taste disturbances, decreased appetite, and fatigue. These are typically mild and self-limiting. Persistent or severe symptoms warrant medical consultation.

Dosage and Administration

The standard adult dosage is one Ifin tablet (250mg) administered once daily. Precise dosing parameters are determined by the treating physician based on infection characteristics and therapeutic response. Treatment continuation for the full prescribed duration is essential, regardless of symptomatic improvement, to ensure complete eradication.

Precautions and Contraindications

Ifin is contraindicated in patients with known hypersensitivity to terbinafine or formulation excipients. Caution is advised in patients with hepatic impairment, renal dysfunction, or immunocompromised states. Pregnancy and lactation require careful risk-benefit assessment under medical supervision.

Storage Instructions

Maintain Ifin at controlled room temperature (15-30°C) in a dry environment protected from light. Avoid storage in humid areas such as bathrooms. Keep securely packaged and out of reach of pediatric patients and animals.